BPG is committed to discovery and dissemination of knowledge
Case Control Study
©The Author(s) 2025.
World J Gastroenterol. Dec 14, 2025; 31(46): 113172
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.113172
Table 1 Univariate analysis of biomarker intensities: Comparison of inflammatory bowel disease vs non-inflammatory bowel disease patients, mean ± SD
Biomarker
IBD (n = 155)
Non-IBD (n = 91)
P value
CCL2101 ± 42.9108 ± 43.70.239
CCL51650 ± 10101710 ± 6650.526
CCL7249 ± 135244 ± 1200.761
IL-827.1 ± 1518.93 ± 4.630.138
TSLP269 ± 123265 ± 1320.812
CCL345.6 ± 15.744.0 ± 13.10.409
CXCL1347 ± 289306 ± 2750.267
CXCL2200 ± 197196 ± 2250.892
CXCL93980 ± 32501440 ± 1460< 0.001
IL-18169 ± 187134 ± 2160.204
IL-2252.8 ± 16331.9 ± 13.60.113
TARC326 ± 461331 ± 2410.913


Write to the Help Desk